Beacon Investment Advisory Services, Inc. Abb Vie Inc. Transaction History

Beacon Investment Advisory Services, Inc.

$2.29 Billion
Q1 2024

A detailed history of Beacon Investment Advisory Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 73,947 shares of ABBV stock, worth $12.4 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

73,947

Previous 61,528 20.18%

Holding current value

$12.4 Million

Previous $9.53 Million 41.23%

% of portfolio

0.59%

Previous 0.44%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $1.98 Million - $2.26 Million	12,419 Added 20.18%	73,947 $13.5 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $1.67 Million - $1.88 Million	12,150 Added 24.61%	61,528 $9.53 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $124,105 - $143,669	-929 Reduced 1.85%	49,378 $7.36 Million
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $470,410 - $585,395	-3,550 Reduced 6.59%	50,307 $6.78 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $30,657 - $35,306	-212 Reduced 0.39%	53,857 $8.58 Million

Q4 2022 Jan 13, 2023	SELL	$138.31 - $165.87 $335,401 - $402,234	-2,425 Reduced 4.29%	54,069 $0
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $200,107 - $229,509	-1,491 Reduced 2.57%	56,494 $7.58 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $238,357 - $303,030	-1,732 Reduced 2.9%	57,985 $8.88 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $372,051 - $461,611	-2,819 Reduced 4.51%	59,717 $9.68 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $240,428 - $304,211	-2,238 Reduced 3.46%	62,536 $8.47 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $601,160 - $682,407	-5,650 Reduced 8.02%	64,774 $6.99 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $15,991 - $17,815	152 Added 0.22%	70,424 $7.93 Million
Q1 2021 May 21, 2021	SELL	$102.3 - $112.62 $51,456 - $56,647	-503 Reduced 0.71%	70,272 $7.61 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $43,464 - $58,681	-540 Reduced 0.76%	70,775 $7.58 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $601 - $705	-7 Reduced 0.01%	71,315 $6.25 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $231,702 - $310,052	-3,158 Reduced 4.24%	71,322 $7 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $2.42 Million - $3.67 Million	-37,500 Reduced 33.49%	74,480 $5.68 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $7.56 Million - $9.46 Million	104,789 Added 1457.22%	111,980 $9.92 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $360,371 - $433,269	-5,722 Reduced 44.31%	7,191 $545,000
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $8.24 Million - $10.5 Million	-125,404 Reduced 90.66%	12,913 $939,000
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $712,156 - $838,173	-9,232 Reduced 6.26%	138,317 $11.1 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $1.14 Million - $1.41 Million	14,647 Added 11.02%	147,549 $13.6 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $428,012 - $475,815	-4,814 Reduced 3.5%	132,902 $12.6 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $200,209 - $236,892	-2,230 Reduced 1.59%	137,716 $12.8 Million
Q1 2018 Apr 26, 2018	BUY	$92.01 - $123.21 $287,163 - $384,538	3,121 Added 2.28%	139,946 $13.2 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $1.37 Million - $1.5 Million	-15,304 Reduced 10.06%	136,825 $13.2 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $10.6 Million - $13.6 Million	152,129	152,129 $13.5 Million

Others Institutions Holding ABBV

# of Institutions

3,655

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.

Account

Beacon Investment Advisory Services, Inc. Abb Vie Inc. Transaction History